Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren's syndrome.


Journal

RMD open
ISSN: 2056-5933
Titre abrégé: RMD Open
Pays: England
ID NLM: 101662038

Informations de publication

Date de publication:
2019
Historique:
received: 23 07 2019
revised: 26 09 2019
accepted: 29 09 2019
entrez: 22 11 2019
pubmed: 22 11 2019
medline: 28 4 2020
Statut: epublish

Résumé

To evaluate current evidence on the efficacy and safety of topical and systemic medications in patients with primary Sjögren syndrome (SjS) to inform European League Against Rheumatism treatment recommendations. The MEDLINE, EMBASE and Cochrane databases were searched for case-control/prospective cohort studies, randomised controlled trials (RCTs) and systematic reviews. Current evidence in primary SjS patients fulfilling the 2002 criteria is based on the data from 9 RCTs, 18 prospective cohort studies and 5 case-control studies. Two Cochrane systematic literature reviews (SLRs) have reported that topical treatments for dry mouth and dry eye are safe and effective. Ocular cyclosporine A was safe and effective in two RCTs including 1039 patients with dry eye syndrome. Two Cochrane SLRs on serum tear drops and plugs showed inconsistency in possible benefits, both for symptoms and objective measures. Five RCTs reported significant improvements in oral dryness and salivary flow rates for pilocarpine and cevimeline. An RCT showed no significant placebo-differences for hydroxychloroquine 400 mg/day for the primary outcome (visual analogue scale (VAS) composite of dryness, fatigue and pain). We identified seven RCTs carried out in primary SjS patients. RCTs using infliximab, anakinra and baminercept found no placebo-differences for the primary outcomes. The two largest RCTs randomised 255 patients to receive rituximab or placebo and reported no significant results in the primary outcome (VAS composite), while prospective studies suggested efficacy in systemic disease. The current evidence supporting the use of the main topical therapeutic options of primary SjS is solid, while limited data from RCTs are available to guide systemic therapies.

Identifiants

pubmed: 31749986
doi: 10.1136/rmdopen-2019-001064
pii: rmdopen-2019-001064
pmc: PMC6827762
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e001064

Subventions

Organisme : Medical Research Council
ID : G0800629
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: SB’s salary is part funded by the Birmingham Biomedical Research Centre.

Références

Arthritis Rheum. 2011 Jan;63(1):180-90
pubmed: 20882668
Ann Rheum Dis. 2014 Jul;73(7):1393-6
pubmed: 24473674
Nat Rev Rheumatol. 2012 May 01;8(7):399-411
pubmed: 22549247
Arthritis Rheumatol. 2017 Jul;69(7):1440-1450
pubmed: 28296257
Cont Lens Anterior Eye. 2015 Oct;38(5):373-8
pubmed: 25956572
Clin Exp Rheumatol. 2014 Jul-Aug;32(4):575-7
pubmed: 25065774
Cochrane Database Syst Rev. 2017 Feb 28;2:CD009327
pubmed: 28245347
Ann Rheum Dis. 2007 Aug;66(8):1026-32
pubmed: 17223657
Joint Bone Spine. 2018 Jan;85(1):15-22
pubmed: 28673789
Cochrane Database Syst Rev. 2013 Aug 30;(8):CD009603
pubmed: 23996155
PLoS One. 2012;7(1):e30123
pubmed: 22253903
Rheumatol Int. 2011 Aug;31(8):1045-9
pubmed: 20309693
Ophthalmology. 2000 May;107(5):967-74
pubmed: 10811092
Clin Exp Rheumatol. 1993 Mar-Apr;11(2):149-56
pubmed: 8508556
Rheumatol Int. 2013 Oct;33(10):2543-8
pubmed: 23649850
Br J Ophthalmol. 2006 Feb;90(2):166-70
pubmed: 16424527
Clin Oral Investig. 2008 Jun;12(2):165-72
pubmed: 18000691
Rheumatol Int. 2011 Dec;31(12):1567-70
pubmed: 20490802
Arthritis Rheum. 2012 Mar;64(3):843-53
pubmed: 22147661
J Korean Med Sci. 2016 Jul;31(7):1127-35
pubmed: 27366013
Cornea. 2004 Nov;23(8):784-92
pubmed: 15502479
Cornea. 2015 Oct;34(10):1214-20
pubmed: 26226470
Arthritis Rheum. 2007 Mar 15;57(2):310-7
pubmed: 17330280
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Jul;110(1):62-7
pubmed: 20610299
JAMA. 2010 Jul 28;304(4):452-60
pubmed: 20664046
Arthritis Care Res (Hoboken). 2013 Nov;65(11):1862-8
pubmed: 23740889
Lupus. 2010 Jul;19(8):941-8
pubmed: 20581017
JAMA. 2014 Jul 16;312(3):249-58
pubmed: 25027140
Clin Rheumatol. 2016 Sep;35(9):2203-10
pubmed: 27470087
Medicine (Baltimore). 2015 Feb;94(7):e551
pubmed: 25700323
Int Immunopharmacol. 2015 Aug;27(2):194-9
pubmed: 25899085
Ann Rheum Dis. 2015 May;74(5):859-66
pubmed: 24442883
Ophthalmology. 2005 Oct;112(10):1790-4
pubmed: 16102833
Arthritis Res Ther. 2013 Oct 30;15(5):R172
pubmed: 24286296
J Inflamm (Lond). 2017 Nov 21;14:26
pubmed: 29200970
Cochrane Database Syst Rev. 2016 Feb 23;2:CD009729
pubmed: 26905373
Ocul Surf. 2015 Apr;13(2):118-32
pubmed: 25881996
Drugs. 2016 Nov;76(17):1601-1623
pubmed: 27844414
Am J Nephrol. 2017;46(6):473-480
pubmed: 29241210
Arthritis Care Res (Hoboken). 2019 May 6;:null
pubmed: 31058469
Arthritis Res Ther. 2007;9(6):R115
pubmed: 17986340
Rheumatology (Oxford). 2015 Dec;54(12):2249-56
pubmed: 26242856
Ann Rheum Dis. 2007 Jan;66(1):107-12
pubmed: 16728458
Cochrane Database Syst Rev. 2017 Jun 26;6:CD006775
pubmed: 28649802
J Rheumatol. 2004 Jan;31(1):96-101
pubmed: 14705226
Ann Rheum Dis. 2017 Jan;76(1):9-16
pubmed: 27789466
Arthritis Rheum. 2004 Apr;50(4):1270-6
pubmed: 15077311
Arthritis Rheum. 2005 Sep;52(9):2740-50
pubmed: 16142737
Ann Rheum Dis. 2002 Jun;61(6):554-8
pubmed: 12006334
JAMA Intern Med. 2018 Feb 1;178(2):181-182
pubmed: 29297040
Arthritis Rheumatol. 2018 Sep;70(9):1470-1480
pubmed: 29604186
Clin Rheumatol. 2007 Aug;26(8):1320-7
pubmed: 17221146
Br J Ophthalmol. 2014 Aug;98(8):1016-22
pubmed: 24344232
Cornea. 2015 Sep;34(9):1072-8
pubmed: 26147835
Ann Rheum Dis. 2008 Nov;67(11):1541-4
pubmed: 18276741
Nat Rev Dis Primers. 2016 Jul 07;2:16047
pubmed: 27383445
Ann Intern Med. 2014 Feb 18;160(4):233-42
pubmed: 24727841
Arthritis Rheum. 2013 Mar;65(3):814
pubmed: 23565525
Ann Rheum Dis. 2011 Jun;70(6):968-72
pubmed: 21345815
Arthritis Rheum. 2013 Apr;65(4):1097-106
pubmed: 23334994
Arthritis Rheum. 2004 Jul;50(7):2240-5
pubmed: 15248223
Ann Rheum Dis. 2016 Feb;75(2):382-9
pubmed: 25480887
Arthritis Rheum. 2010 Apr;62(4):960-8
pubmed: 20131246
Arthritis Res Ther. 2006;8(4):R129
pubmed: 16859536
Ann Rheum Dis. 2015 Mar;74(3):526-31
pubmed: 24347569

Auteurs

Pilar Brito-Zerón (P)

Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA-Sanitas, Barcelona, Spain.
Laboratory of Autoimmune Diseases Josep Font, CELLEX, IDIBAPS, Barcelona, Spain.

Soledad Retamozo (S)

Department of Rheumatology, Instituto Modelo de Cariología Privado S.R.L, Instituto Universitario de Ciencias Biomédicas de Córdoba, Cordoba, Argentina.
Instituto De Investigaciones En Ciencias De La Salud (INICSA), Universidad Nacional de Córdoba (UNC), Cordoba, Argentina.

Belchin Kostov (B)

Research Primary Healthcare Transversal Research Group, CAP Les Corts, CAPSBE, IDIBAPS, Barcelona, Spain.
Statistics and Operations Research Department, Universitat Politecnica de Catalunya, Barcelona, Spain.

Chiara Baldini (C)

Rheumatology Unit, Universita degli Studi di Pisa, Pisa, Italy.

Hendrika Bootsma (H)

Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Salvatore De Vita (S)

Clinic of Rheumatology, University Hospital Santa Maria della Misericordia, Udine, Italy.

Thomas Dörner (T)

Department of Medicine/Rheumatology and Clinical Immunology and DRFZ, Charité Universitätsmedizin Berlin Campus Charite Mitte, Berlin, Germany.

Jacques-Eric Gottenberg (JE)

Department of Rheumatology, Strasbourg University Hospital, National Reference Center for Rare Systemic Autoimmune Diseases, CNRS, IBMC, UPR 3572, Université de Strasbourg, Strasbourg, France.

Aike A Kruize (AA)

Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.

Thomas Mandl (T)

Department of Rheumatology, Skane University Hospital Malmö, Lund University, Lund, Sweden.

Wan-Fai Ng (WF)

NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK.

Raphaele Seror (R)

Department of Rheumatology, Assistance Publique - Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Le Kremlin-Bicetre, France.
Center for Immunology of Viral Infections and Autoimmune Diseases, INSERM UMR 1184, Université Paris-Sud, Université Paris-Saclay, Paris, France.

Athanasios G Tzioufas (AG)

Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Claudio Vitali (C)

Villa San Giuseppe, Istituto S. Stefano, Como, Italy.

Simon Bowman (S)

Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Xavier Mariette (X)

Department of Rheumatology, Assistance Publique - Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Le Kremlin-Bicetre, France.
Center for Immunology of Viral Infections and Autoimmune Diseases, INSERM UMR 1184, Université Paris-Sud, Université Paris-Saclay, Paris, France.

Manuel Ramos-Casals (M)

Laboratory of Autoimmune Diseases Josep Font, CELLEX, IDIBAPS, Barcelona, Spain.
Department of Autoimmune Diseases, ICMiD, Hospital Clinic de Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH